(Q36376434)

13 August 2017

1 reference

title

Neuropharmacology and potential efficacy of new treatments for tobacco dependence (English)

1 reference

13 August 2017

1 reference

Karl Fagerström

1

1 reference

PubMed ID

16433591

13 August 2017

David J K Balfour

series ordinal

2

1 reference

PubMed ID

16433591

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Expert Opinion on Investigational Drugs

13 August 2017

1 reference

13 August 2017

15

1 reference

13 August 2017

2

1 reference

13 August 2017

107-116

1 reference

Sensitization of the mesoaccumbens dopamine response to nicotine.

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Dopaminergic mechanisms in the locomotor stimulant effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Cue dependency of nicotine self-administration and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Neurobiology of the nicotine withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Nicotine dependence: studies with a laboratory model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Differential control over cocaine-seeking behavior by nucleus accumbens core and shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Nicotine activates and desensitizes midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Importance of nonpharmacological factors in nicotine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Role of nicotine dose and sensory cues in the regulation of smoke intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Dissociating nicotine and nonnicotine components of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

CB1 receptor antagonists for the treatment of nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Investigations using immunization to attenuate the psychoactive effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.2.107

10.1517/13543784.15.2.107

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16433591